Back
KalVista Pharmaceuticals Stock Predictions
Sponsored
KALV
Sponsored
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the corner
Buy
66
KALV
KalVista Pharmaceuticals
Last Price:
12.11
Seasonality Move:
-5.6%
7 Day Trial
ALL ACCESS PASS
$
7
Elon's Secret "A.I. 2.0" Project
Click here now to discover how to claim a stake in Elon's "A.I. 2.0" projectKalVista Pharmaceuticals Stock Forecast
- Over the next 52 weeks, KalVista Pharmaceuticals has on average historically risen by 7.2% based on the past 9 years of stock performance.
- KalVista Pharmaceuticals has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
-
Is KalVista Pharmaceuticals Stock Undervalued?
The current KalVista Pharmaceuticals [KALV] share price is $12.13. The Score for KALV is 66, which is 32% above its historic median score of 50, and infers lower risk than normal. - KALV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will KalVista Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, KalVista Pharmaceuticals has on average historically risen by 7.2% based on the past 9 years of stock performance.
KalVista Pharmaceuticals Stock Rating
Buy
66
KalVista Pharmaceuticals (KALV)
is a Buy
Is KalVista Pharmaceuticals overpriced?
- KalVista Pharmaceuticals has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
KalVista Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kalvista.com
52-Week Data
52-Week High:
16.88
52-Week Low:
7.21
Prediction Charts
Market Cap:
511.74M
Price in USD:
12.13
Volume:
199.66K
Beta:
1.28
Technical Analysis
SMA50:
12.14
SMA100:
12.53
SMA200:
11.01
52-Wk Change:
32.28%
Stock Predictions
-
Is KalVista Pharmaceuticals stock public?
Yes, KalVista Pharmaceuticals is a publicly traded company. -
What is the KalVista Pharmaceuticals stock quote today?
The KalVista Pharmaceuticals stock price is 12.13 USD today. -
How to buy KalVista Pharmaceuticals stock online?
You can buy KalVista Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-16 | 11.53 | 11.88 | 12.17 | 11.47 |
Apr-17 | 11.80 | 11.65 | 11.94 | 11.65 |
Apr-18 | 11.53 | 11.51 | 11.75 | 11.28 |
Apr-19 | 11.42 | 11.59 | 11.78 | 11.27 |
Apr-22 | 11.61 | 11.44 | 11.78 | 11.36 |
Apr-23 | 11.43 | 11.19 | 11.71 | 11.19 |
Apr-24 | 11.18 | 10.35 | 11.18 | 10.32 |
Apr-25 | 10.12 | 10.49 | 10.52 | 10.11 |
Apr-26 | 10.50 | 10.78 | 10.81 | 10.26 |
Apr-29 | 10.92 | 11.01 | 11.19 | 10.88 |
Apr-30 | 11.00 | 11.36 | 11.40 | 10.92 |
May-1 | 11.35 | 12.18 | 12.52 | 11.35 |
May-2 | 12.23 | 12.16 | 12.30 | 11.75 |
May-3 | 12.24 | 12.13 | 12.48 | 11.96 |
KalVista Pharmaceuticals Earnings
KalVista Pharmaceuticals Earnings Report: Per Share KalVista Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
KalVista Pharmaceuticals Forecast Revenue Growth
KalVista Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for KalVista Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.40 per share, and an increase next year of $0.62 per share.
* KalVista Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.